Acute promyelocytic leukaemia (APL) is a specific type of acute myeloid leukaemia (AML) characterised by t(15;17) translocation, promyelocytic leukaemia gene‐retinoic acid receptor alpha (PML::RARA) fusion oncoprotein transcripts and abnormal promyelocyte predomination (1, 2). Here, RARA is linked to acute myeloid leukemia.